Lipid malabsorption persists after weaning in rats whose dams were given GLP-2 and dexamethasone - PubMed

Lipid malabsorption persists after weaning in rats whose dams were given GLP-2 and dexamethasone

Claudiu Iordache et al. Lipids. 2005 Nov.

Abstract

Glucagon-like peptide-2 (GLP-2) enhances intestinal growth and absorption in mature animals, and glucocorticosteroids (GC) increase the sugar and lipid uptake in adult animals. However, the role of GC and GLP-2 in the ontogeny of lipid absorption is unknown. We hypothesized that GLP-2 and the GC dexamethasone (DEX), when administrated to rat dams during pregnancy and lactation, would enhance lipid uptake in the offspring. Rat dams were treated in the last 10 d of pregnancy and during lactation with GLP-2 [0.1 microg/g/d subcutaneous (sc)], DEX (0.128 microg/g/d sc), GLP-2 + DEX, or a placebo. Sucklings were sacrificed at 19-21 d of age, and weanlings were sacrificed 4 wk later. Lipid uptake was assessed using an in vitro ring uptake method. Although DEX and GLP-2 + DEX increased the jejunal mass, the jejunal lipid uptake was unchanged. In contrast, GLP-2, DEX, and GLP-2 + DEX reduced the ileal lipid uptake in suckling and weanling rats. This reduction was not due to alterations in intestinal morphology or to changes in fatty acid-binding protein abundance, but it was partially explained by an increase in the effective resistance of the intestinal unstirred water layer. In sucklings, DEX dramatically reduced the jejunal lipid uptake to levels similar to those seen in weanlings, such that the normal ontogenic decline in lipid uptake was not observed. Giving dams GLP-2 or DEX during pregnancy and lactation reduced lipid uptake in the offspring, and this persisted for at least 1 mon. The impact this may have on the nutritional well-being of the animal in later life is unknown.

Similar articles

• Dexamethasone plus glucagon-like peptide 2 given to lactating rat dams has a late effect on intestinal lipid uptake in the weanling offspring.

  Iordache C, Drozdowski L, Clandinin T, Wild G, Todd Z, Thomson AB. Iordache C, et al. JPEN J Parenter Enteral Nutr. 2004 Sep-Oct;28(5):355-63. doi: 10.1177/0148607104028005355. JPEN J Parenter Enteral Nutr. 2004. PMID: 15449577

• A combination of dexamethasone and glucagon-like peptide-2 increase intestinal morphology and glucose uptake in suckling rats.

  Drozdowski LA, Iordache C, Clandinin MT, Wild G, Todd Z, Thomson AB. Drozdowski LA, et al. J Pediatr Gastroenterol Nutr. 2006 Jan;42(1):32-9. doi: 10.1097/01.mpg.0000187246.60560.16. J Pediatr Gastroenterol Nutr. 2006. PMID: 16385251

• Treatment of suckling rats with GLP-2 plus dexamethasone increases the ileal uptake of fatty acids in later life.

  Iordache C, Drozdowski L, Clandinin MT, Wild G, Todd Z, Thomson AB. Iordache C, et al. Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G54-9. doi: 10.1152/ajpgi.00047.2004. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15591587

• Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

  Martin GR, Beck PL, Sigalet DL. Martin GR, et al. World J Gastroenterol. 2006 Jul 14;12(26):4117-29. doi: 10.3748/wjg.v12.i26.4117. World J Gastroenterol. 2006. PMID: 16830359 Free PMC article. Review.

• Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.

  Mulvihill EE. Mulvihill EE. Curr Opin Lipidol. 2018 Apr;29(2):95-103. doi: 10.1097/MOL.0000000000000495. Curr Opin Lipidol. 2018. PMID: 29432213 Free PMC article. Review.

Cited by

• Recent advances in small bowel diseases: Part I.

  Thomson AB, Chopra A, Clandinin MT, Freeman H. Thomson AB, et al. World J Gastroenterol. 2012 Jul 14;18(26):3336-52. doi: 10.3748/wjg.v18.i26.3336. World J Gastroenterol. 2012. PMID: 22807604 Free PMC article. Review.

References

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer
  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal